Outsourcing gap widens: Europe pulls away from US in new drug manufacturing
In 2025, the dose outsourcing gap between the proportion of newly approved biosimilar and innovator products outsourced to European and…
In 2025, the dose outsourcing gap between the proportion of newly approved biosimilar and innovator products outsourced to European and…